Literature DB >> 1909049

Dietary n-6 fatty acids inhibit the incorporation of dietary n-3 fatty acids in thrombocyte and serum phospholipids in humans: a controlled dietetic study.

M Grønn1, C Gørbitz, E Christensen, A Levorsen, L Ose, T A Hagve, B O Christophersen.   

Abstract

The effect of a high dietary intake of n-6 fatty acids (36 g daily) vs a low intake (4-6 g daily) on the incorporation of fatty acids from a dietary supplementation of n-3 fatty acids (6 g daily) was studied for 8 weeks in 15 healthy, normolipaemic volunteers. The importance of a high (43.6) vs a low (20.6) energy percentage from fat was also investigated in the participants on a low n-6 intake. Fatty acid analyses of serum and thrombocyte phospholipids showed a marked increase in docosahexaenoic acid (22:6 (n-3), DHA) and especially eicosapentaenoic acid (20:5 (n-3), EPA) in both the high and low n-6 groups after 14 days, but the changes were significantly greater in the low n-6 diet groups. Changes of the ratio between EPA and arachidonic acid (20:4 (n-6), AA) in phospholipids followed an identical pattern in serum and thrombocytes. This indicates that thrombocytes are influenced by the fatty acid composition in serum. The results showed that incorporation of n-3 fatty acids in phospholipids was reduced by a high intake of dietary n-6 fatty acids in the cells and lipid fractions studied. The observed effect of dietary n-6 fatty acids was independent of the energy percentage provided by dietary fat. In order to obtain an optimal effect of n-3 supplementation, the intake of linoleic acid has to be considered and kept at a low level. The serum content of cholesterol was unaffected, but the concentration of triacylglycerol was reduced during the supplementation period.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1909049     DOI: 10.3109/00365519109091612

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  7 in total

1.  A new relationship between total/high density lipoprotein cholesterol and polyunsaturated fatty acids.

Authors:  E Siguel
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

2.  The Anti-inflammatory Effect of Personalized Omega-3 Fatty Acid Dosing for Reducing Prostaglandin E2 in the Colonic Mucosa Is Attenuated in Obesity.

Authors:  Zora Djuric; D Kim Turgeon; Ananda Sen; Jianwei Ren; Kirk Herman; Devon Ramaswamy; Lili Zhao; Mack T Ruffin; Daniel P Normolle; William L Smith; Dean E Brenner
Journal:  Cancer Prev Res (Phila)       Date:  2017-11-13

3.  Dietary polyunsaturated fatty acids modulate adipose secretome and is associated with changes in mammary epithelial stem cell self-renewal.

Authors:  Evan M Hill; Raymond M Esper; Ananda Sen; Becky R Simon; Muhammad N Aslam; Yan Jiang; Michael K Dame; Shannon D McClintock; Justin A Colacino; Zora Djuric; Max S Wicha; William L Smith; Dean E Brenner
Journal:  J Nutr Biochem       Date:  2019-05-24       Impact factor: 6.048

4.  Vegetarian diets are associated with healthy mood states: a cross-sectional study in seventh day adventist adults.

Authors:  Bonnie L Beezhold; Carol S Johnston; Deanna R Daigle
Journal:  Nutr J       Date:  2010-06-01       Impact factor: 3.271

5.  The activities of acyl-CoA:1-acyl-lysophospholipid acyltransferase(s) in human platelets.

Authors:  A M Bakken; M Farstad
Journal:  Biochem J       Date:  1992-12-15       Impact factor: 3.857

Review 6.  Dietary linoleic acid and risk of coronary heart disease: a systematic review and meta-analysis of prospective cohort studies.

Authors:  Maryam S Farvid; Ming Ding; An Pan; Qi Sun; Stephanie E Chiuve; Lyn M Steffen; Walter C Willett; Frank B Hu
Journal:  Circulation       Date:  2014-08-26       Impact factor: 29.690

7.  Generalized peroxisomal disorder in male twins: fatty acid composition of serum lipids and response to n-3 fatty acids.

Authors:  O Søvik; J E Månsson; A L Bjorke Monsen; E Jellum; R K Berge
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.